Liu Y - Search Results

1

Interferon-α induces G1 cell-cycle arrest in renal cell carcinoma cells via activation of Jak-Stat signaling.

Shang D, Yang P, Liu Y, Song J, Zhang F, Tian Y. Shang D, et al. Among authors: liu y. Cancer Invest. 2011 Jun;29(5):347-52. doi: 10.3109/07357907.2011.568566. Cancer Invest. 2011. PMID: 21599510

2

Defective Jak-Stat activation in renal cell carcinoma is associated with interferon-alpha resistance.

Shang D, Liu Y, Ito N, Kamoto T, Ogawa O. Shang D, et al. Among authors: liu y. Cancer Sci. 2007 Aug;98(8):1259-64. doi: 10.1111/j.1349-7006.2007.00526.x. Epub 2007 Jun 15. Cancer Sci. 2007. PMID: 17573897 Free PMC article.

3

Synergy of 5-aza-2'-deoxycytidine (DAC) and paclitaxel in both androgen-dependent and -independent prostate cancer cell lines.

Shang D, Liu Y, Liu Q, Zhang F, Feng L, Lv W, Tian Y. Shang D, et al. Among authors: liu y, liu q. Cancer Lett. 2009 Jun 8;278(1):82-7. doi: 10.1016/j.canlet.2008.12.034. Epub 2009 Jan 24. Cancer Lett. 2009. PMID: 19168279

4

5-aza-2'-deoxycytidine enhances susceptibility of renal cell carcinoma to paclitaxel by decreasing LEF1/phospho-β-catenin expression.

Shang D, Liu Y, Xu X, Han T, Tian Y. Shang D, et al. Among authors: liu y. Cancer Lett. 2011 Dec 8;311(2):230-6. doi: 10.1016/j.canlet.2011.08.012. Epub 2011 Aug 22. Cancer Lett. 2011. PMID: 21880414

5

TGFBI-promoted adhesion, migration and invasion of human renal cell carcinoma depends on inactivation of von Hippel-Lindau tumor suppressor.

Shang D, Liu Y, Yang P, Chen Y, Tian Y. Shang D, et al. Among authors: liu y. Urology. 2012 Apr;79(4):966.e1-7. doi: 10.1016/j.urology.2011.12.011. Epub 2012 Feb 15. Urology. 2012. PMID: 22341602

6

Protein tyrosine phosphatase ζ enhances proliferation by increasing β-catenin nuclear expression in VHL-inactive human renal cell carcinoma cells.

Shang D, Xu X, Wang D, Li Y, Liu Y. Shang D, et al. Among authors: liu y. World J Urol. 2013 Dec;31(6):1547-54. doi: 10.1007/s00345-013-1077-4. Epub 2013 Apr 16. World J Urol. 2013. PMID: 23588815

7

Expression and proliferation-promoting role of lymphoid enhancer-binding factor 1 in human clear cell renal carcinoma.

Shang D, Bi R, Han T, Wang D, Tian Y, Liu Y. Shang D, et al. Among authors: liu y. Cancer Invest. 2014 Aug;32(7):368-74. doi: 10.3109/07357907.2014.919307. Epub 2014 Jun 4. Cancer Invest. 2014. PMID: 24897388

8

Decitabine induces G2/M cell cycle arrest by suppressing p38/NF-κB signaling in human renal clear cell carcinoma.

Shang D, Han T, Xu X, Liu Y. Shang D, et al. Among authors: liu y. Int J Clin Exp Pathol. 2015 Sep 1;8(9):11140-8. eCollection 2015. Int J Clin Exp Pathol. 2015. PMID: 26617834 Free PMC article.

9

Epirubicin suppresses proliferative and metastatic potential by downregulating transforming growth factor-β-induced expression in urothelial carcinoma.

Shang D, Song B, Liu Y. Shang D, et al. Among authors: liu y. Cancer Sci. 2018 Apr;109(4):980-987. doi: 10.1111/cas.13403. Epub 2018 Feb 20. Cancer Sci. 2018. PMID: 28940965 Free PMC article.

10

Transforming growth factor-β1 enhances proliferative and metastatic potential by up-regulating lymphoid enhancer-binding factor 1/integrin αMβ2 in human renal cell carcinoma.

Liu Y, Shang D. Liu Y, et al. Mol Cell Biochem. 2020 Feb;465(1-2):165-174. doi: 10.1007/s11010-019-03676-8. Epub 2019 Dec 17. Mol Cell Biochem. 2020. PMID: 31848806

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

210,455 results

Search Page

Filters